Clinical Trials on Vaginosis, Bacterial in New Zealand

Total 1942 results

Atlantic Health System

Recruiting

Evaluation of a Novel Female Hygiene Device for Postcoital Discomfort

Vaginitis | Female Sexual Dysfunction | Vaginal Discharge | Dyspareunia | Bacterial Vaginoses

United States
University of New Mexico

Completed

Trial of Trimosan Gel Effect on Pessary-associated Bacterial Vaginosis (TBVAP)

Bacterial Vaginosis

United States
Teva Pharmaceuticals USA

Completed

Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis

Bacterial Vaginosis

United States
Symbiomix Therapeutics

Completed

A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis

Bacterial Vaginosis

United States
Symbiomix Therapeutics

Completed

A Phase 3 Study of SYM-1219 Treatment of Women and Post-Menarchal Adolescent Girls With Bacterial Vaginosis

Bacterial Vaginosis

United States
Daré Bioscience, Inc.

Completed

DARE-BV1 in the Treatment of Bacterial Vaginosis (DARE-BVFREE)

Bacterial Vaginosis

United States
Centers for Disease Control and Prevention
Tulane University School of Public Health and Tropical Medicine

Suspended

Brief, Behavioral Intervention to Reduce Douching Among Adolescent and Young Women

Bacterial Vaginosis | Vaginal Douching

United States
Symbiomix Therapeutics

Completed

Open-Label Study to Evaluate Safety of A Single Dose of SYM-1219

Bacterial Vaginosis

United States
Medicis Global Service Corporation

Completed

Safety and Efficacy Study to Treat Bacterial Vaginosis

Bacterial Vaginosis

United States
AtoGen Co. Ltd
ATOGEN AUSTRALIA PTY LTD

Recruiting

Safety, Tolerability, and Acceptability Study of Intravaginal Administration of LABTHERA-001 Capsules in Healthy Women

Bacterial Infections | Vaginal Disease | Vaginitis | Infection, Bacterial | Bacterial Vaginosis

Australia
Vaginal Biome Science
Concord Hospital

Completed

Clinical Trial to Survey Results of Flourish Vaginal Care System for Recurrent Bacterial Vaginosis

Vaginal Flora Imbalance | Bacterial Vaginosis

United States
Starpharma Pty Ltd

Completed

Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)

Bacterial Vaginosis

United States, Puerto Rico, Canada
Graceway Pharmaceuticals, LLC

Completed

Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis

Vaginosis, Bacterial | Vaginal Infection

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Empiric Therapy of Mucopurulent Cervicitis (MPC)

Cervicitis | Vaginitis Bacterial

United States
Insud Pharma
Allergan Sales, LLC

Completed

Safety and Tolerability of Metronidazole Gel 1.3%

Vaginosis, Bacterial

United States
Actavis Inc.
Watson Laboratories, Inc.

Completed

A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women

BACTERIAL VAGINOSIS | Signs and Symptoms to be Evaluated and Recorded Include | Vaginal Discharge Color, Odor, and Consistency | Vulvovaginal Itching and Irritation (Subjective) Absent, Mild, Moderate, or Severe | Vulvovaginal Inflammation (Objective) Absent, Mild, Moderate, or Severe

United States, Dominican Republic, Puerto Rico
Capital and Coast District Health board
Wellington Southern Community Laboratories; Institute of Environmental Science...

Recruiting

Evaluation of a mNGS Workflow for Infection Diagnosis Using Oxford Nanopore Sequencing.

Bacterial Infections

New Zealand
Endologix

Completed

PQ Bypass Guide Wire Delivery System for Femoropopliteal Bypass (PQB4FP1)

Peripheral Arterial Disease

New Zealand
Avinger, Inc.

Withdrawn

Trial of Pantheris System, an Atherectomy Device That Provides Imaging While Removing Plaque in Lower Extremity Arteries (COMBINE-II)

Peripheral Arterial Disease

New Zealand
AmtixBio Co., Ltd.
Novotech (Australia) Pty Limited

Completed

A Study of ATB1651 in Adults With Mild to Moderate Onychomycosis

Onychomycosis

New Zealand
AmtixBio Co., Ltd.

Not yet recruiting

A Study of ATB1651 in Adults With Mild to Moderate Onchomycosis

Onychomycosis

New Zealand
Terumo Medical Corporation

Recruiting

Kaitoh Atherectomy FIH

Peripheral Arterial Disease

New Zealand
W.L.Gore & Associates

Completed

Evaluation of the GORE® VIABAHN® BALLOON EXPANDABLE ENDOPROSTHESIS (VIABAHN BX)

Peripheral Arterial Disease | Common Iliac Artery Occlusive Disease | External Iliac Artery Occlusive Disease

New Zealand
Spectranetics Corporation

Completed

Pharmacokinetic Study of Drug-coated Angioplasty Balloons in the Superficial Femoral or Popliteal Arteries: (PK)

Peripheral Artery Disease

New Zealand
Ellume Pty Ltd

Withdrawn

Performance of Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Participants With Acute Pharyngitis

Group A Streptococcal Infection

New Zealand
Starship Child Health, Te Toka Tumai Auckland
Menzies School of Health Research; Health Research Council, New Zealand

Not yet recruiting

TREAT-SC: Early, Short Course Oral Dexamethasone for the Treatment of Sydenham Chorea in Children (TREAT-SC)

Rheumatic Fever | Sydenham Chorea

Australia, New Zealand
TriReme Medical, LLC

Completed

Drug-Coated Chocolate PTA Balloon in Patients With Peripheral Arterial Disease - The ENDURE Trial (ENDURE)

Peripheral Vascular Disease

New Zealand, Germany
Medtronic Vascular

Completed

Bare Metal Bifurcation Stent Clinical Trial in Humans (BRANCH)

Myocardial Ischemia | Coronary Artery Disease

New Zealand
Shockwave Medical, Inc.

Active, not recruiting

Mini S Feasibility Study With Shockwave Medical Mini S Peripheral IVL System

Peripheral Arterial Disease

New Zealand, Australia
The University of New South Wales

Terminated

The ABSORB Bioresorbable Scaffold Below the Knee (BTK) Study

Ischemia | Arterial Occlusive Diseases | Peripheral Arterial Disease (PTA

New Zealand, Australia, Netherlands
NeuroActiva, Inc.

Completed

A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831

Neurocognitive Disorders | Neurodegenerative Diseases | Cognitive Impairment | Alzheimer Disease | Tauopathies | Mild Cognitive Impairment | Dementia, Vascular | Dementia With Lewy Bodies | Alzheimer Dementia | Cognitive Disorder

New Zealand
Atrium Medical Corporation

Terminated

The Clinical Evaluation of the Cinatra™ Corolimus-Eluting Coronary Stent in De Novo Lesions in Native Coronary Arteries (VANTAGE-1)

Coronary Artery Disease

New Zealand
Cagent Vascular LLC

Completed

PRospective Study for the TrEatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator DevicE (PRELUDE)

Peripheral Arterial Disease

New Zealand, Austria, Poland
Elixir Medical Corporation

Completed

Elixir Medical Clinical Evaluation of the DESolve Myolimus Eluting Bioresorbable Coronary Stent System - DESolve I Trial

Coronary Artery Disease

New Zealand, Belgium
Efemoral Medical, Inc.

Recruiting

The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery (Efemoral I)

Vascular Diseases | Peripheral Arterial Disease | Stenosis | Femoropopliteal Stenosis

New Zealand, Australia
Cidara Therapeutics Inc.

Completed

RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections

Mycoses | Candidiasis, Vulvovaginal | Yeast Infection | Moniliasis, Vulvovaginal | Vaginitis, Monilial

United States
Cidara Therapeutics Inc.

Completed

Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization

Mycoses | Candidiasis, Vulvovaginal | Yeast Infection | Moniliasis, Vulvovaginal | Vaginitis, Monilial

United States
Shockwave Medical, Inc.

Completed

Safety and Performance Study of the Shockwave Lithoplasty System (DISRUPT-PAD)

Peripheral Arterial Disease

Austria, Germany, New Zealand
Amplitude Vascular Systems, Inc.

Active, not recruiting

POWER: Pulse Intravascular Lithotripsy (Pulse IVL) to Open Vessels With Calcific Walls and Enhance Vascular Compliance and Remodeling (POWER-PAD-1)

Peripheral Arterial Disease

Australia, New Zealand, Dominican Republic
ReFlow Medical, Inc.
ClinLogix. LLC

Active, not recruiting

A Study of the Temporary Spur Stent for the Treatment of Narrowing and Blockages in the Arteries Below the Knee (DEEPER OUS)

Peripheral Arterial Disease

New Zealand, Germany, Switzerland
Biotronik CRC Inc.
Biotronik AG

Active, not recruiting

BRight DCB First-in-Human Study

Peripheral Artery Disease

New Zealand, Australia, Germany, Austria
Murdoch Childrens Research Institute
Royal Children's Hospital

Completed

What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)?

Primary Immunodeficiency | Invasive Pneumococcal Disease, Protection Against | Invasive Pneumococcal Disease, Recurrent Isolated, 1 | Invasive Pneumococcal Disease, Recurrent Isolated, 2

Australia, New Zealand
Cordis Corporation
Conor Medsystems

Terminated

Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions (NEVO RES-I)

Coronary Atherosclerosis

Brazil, New Zealand
Shockwave Medical, Inc.

Completed

Safety and Feasibility of the Shockwave Lithoplasty® System for the Treatment of Peripheral Vascular Stenosis (BTK)

Peripheral Arterial Disease

New Zealand, Austria, Germany
Elixir Medical Corporation

Completed

DynamX Sirolimus Study Sirolimus Eluting Coronary Bioadaptor System

Coronary Artery Disease

New Zealand
Cook Group Incorporated

Completed

Zilver PTX Delivery System

Peripheral Vascular Disease

New Zealand, Australia, Germany
Shockwave Medical, Inc.

Completed

Shockwave Lithoplasty DISRUPT Trial for PAD (DISRUPT PAD 2)

Peripheral Arterial Disease

New Zealand, Germany, Austria
Tulane University Health Sciences Center

Completed

Trichomonas Vaginalis Repeat Infections Among HIV Negative Women

Vaginitis Trichomonal or Due to Trichomonas

United States
Elixir Medical Corporation
Massachusetts General Hospital; Syntactx; Genae

Completed

The DESappear Study: Drug Eluting Scaffold (DESappear)

Peripheral Vascular Disease

New Zealand, Austria, Germany, Belgium
Micell Technologies

Completed

First-In-Human Trial of the MiStent Drug-Eluting Stent (DES) in Coronary Artery Disease (DESSOLVE-I)

Coronary Artery Disease

Belgium, Australia, New Zealand

Clinical Trials on Vaginosis, Bacterial in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations